3808
A. Mitrofanov et al.
PAPER
4,7-dibromo-1,10-phenanthroline (11)40 and 2,9-dichloro-1,10-
phenanthroline (12)39 were prepared according to literature meth-
ods. Toluene was dried by distillation over sodium under N2. Pre-
parative column chromatography was performed with SDS silica
gel 60 ACC (Chromagel, particle size 70–200 μm). Analytical TLC
was carried out using silica gel 60 F254 plates (Merck). IR spectra
were recorded on a Bruker IFS 66v spectrophotometer. NMR spec-
tra were recorded with Bruker Avance 300 and 600 instruments; the
chemical shifts (δ) are reported in ppm and the coupling constants
are expressed in Hz. Mass spectra were obtained by ESI on an Or-
bitrap spectrometer. The measurements were undertaken at the
‘Pôle Chimie Moléculaire’, a technological platform for chemical
lies on the Institute of Molecular Chemistry of the University of
Burgundy and Welience®, a Burgundy University private subsid-
iary.
1H NMR (300 MHz, CDCl3): δ = 1.04 (t, 3JHH = 7.1 Hz, 3 H, CH3),
3
3
1.26 (t, JHH = 7.3 Hz, 9 H, CH3), 3.01 (q, JHH = 7.3 Hz, 6 H,
3
3
NCH2), 3.76 (m, 2 H, OCH2), 7.56 (dd, JHH = 8.1 Hz, JHH = 4.4
Hz, 2 H, H-3,8), 8.23 (dd, 3JHH = 8.1 Hz, 4JHH = 1.5 Hz, 1 H, H-7),
3
8.53 (d, JHP = 15.4 Hz, 1 H, H-6), 9.09 (m, 1 H, H-9), 9.14 (dd,
3JHH = 4.4 Hz, 4JHH = 1.5 Hz, 1 H, H-2), 9.29 (d, 3JHH = 8.1 Hz, 1 H,
H-4).
31P NMR (121 MHz, CDCl3): δ = 9.25.
Diethyl 1,10-Phenanthrolin-3-ylphosphonate (7)
Prepared from 3-bromo-1,10-phenanthroline (4; 518 mg, 2 mmol),
Pd(OAc)2 (22.4 mg, 0.1 mmol), dppf (111 mg, 0.2 mmol),
HP(O)(OEt)2 (308 μL, 2.4 mmol) and Et3N (320 μL, 2.4 mmol) in
toluene. The reaction mixture was chromatographed (CH2Cl2–
MeOH, 97.5:2.5) to give phosphonate 7 as a yellow oil; yield: 512
mg (81%).
IR (KBr): 2980, 1618, 1502, 1423, 1237, 1050, 1012, 970 cm–1.
Diethyl 1,10-Phenanthrolin-5-ylphosphonates; General Proce-
dure
1H NMR (300 MHz, CDCl3): δ = 1.35 (t, 3JHH = 7.1 Hz, 6 H), 4.20
(m, 4 H), 7.68 (dd, 3JHH = 8.1 Hz, 3JHH = 4.3 Hz, 1 H, H-8), 7.84 (d,
3JHH = 8.9 Hz, 1 H, H-6), 7.87 (d, 3JHH = 8.9 Hz, 1 H, H-5), 8.27 (dd,
A 25-mL round-bottom flask equipped with a reflux condenser and
a magnetic stirrer bar was charged with the bromo-1,10-phenan-
throline, Pd(OAc)2 and the ligand. The reaction vessel was evacuat-
ed and purged with N2 three times. Subsequently, solvent,
HP(O)(OEt)2 and Et3N were added via syringe. The reaction mix-
ture was stirred at reflux until complete conversion of the bromide,
according to 1H NMR spectroscopy. The reaction mixture was
cooled and then concentrated under reduced pressure. The residue
was taken up in CH2Cl2 (5–10 mL) and the product was isolated by
column chromatography on silica gel.
3
3JHH = 8.1 Hz, 4JHH = 1.7 Hz, 1 H, H-7), 8.76 (dd, JHP = 14.6
3
Hz, 4JHH = 2.0 Hz, 1 H, H-4), 9.21 (dd, JHH = 4.3 Hz, 4JHH = 1.7
Hz, 1 H, H-9), 9.41 (dd, 3JHP = 4.8 Hz, 4JHH = 2.0 Hz, 1 H, H-2).
13C NMR (75 MHz, CDCl3): δ = 16.55 (d, J = 6.1 Hz, 2 C, CH3),
63.93 (d, J = 5.5 Hz, 2 C, CH2), 124.09 (C-8), 124.23 (d, J = 188.2
Hz, C-3), 126.62 (C-5), 127.55 (d, J = 13.0 Hz, C-4a), 127.85 (C-
6), 129.90 (C-6a), 136.30 (C-7), 141.38 (d, J = 8.9 Hz, C-4), 145.94
(C-10a), 148.13 (C-10b), 150.98 (C-9), 151.21 (d, J = 12.1 Hz, C-
2).
Diethyl 1,10-Phenanthrolin-5-ylphosphonate (2)
31P NMR (121 MHz, CDCl3): δ = 15.68.
HRMS: m/z [M + Na]+ calcd for C16H17O3N2NaP: 339.0869; found:
Method A (Table 1, Entry 5)
Prepared from 5-bromo-1,10-phenanthroline (1; 518 mg, 2 mmol),
Pd(OAc)2 (44.9 mg, 0.2 mmol), dppf (222 mg, 0.4 mmol),
HP(O)(OEt)2 (308 μL, 2.4 mmol) and Et3N (320 μL, 2.4 mmol) in
toluene. Diethyl phosphonate 2 was obtained by chromatography
(CH2Cl2–MeOH, 98:2) as a yellow oil; yield: 499 mg (79%).
339.0882.
Diethyl 1,10-Phenanthrolin-4-ylphosphonate (8)
Prepared from 4-bromo-1,10-phenanthroline (5; 518 mg, 2 mmol),
Pd(OAc)2 (44.9 mg, 0.2 mmol), dppf (222 mg, 0.4 mmol),
HP(O)(OEt)2 (308 μL, 2.4 mmol) and Et3N (320 μL, 2.4 mmol) in
dioxane. The reaction mixture was chromatographed (CH2Cl2–
MeOH, 98:2) to give phosphonate 8 as a yellow oil; yield: 330 mg
(52%).
IR (KBr): 2987, 1506, 1447, 1415, 1387, 1251, 1018, 971, 802
cm–1.
1H NMR (300 MHz, CDCl3): δ = 1.28 (t, 3JHH = 7.1 Hz, 6 H), 4.11
(m, 2 H), 4.21 (m, 2 H), 7.69 (dd, 3JHH = 8.3 Hz, 3JHH = 4.4 Hz, 2 H,
H-3,8), 8.33 (dd, 3JHH = 8.1 Hz, 4JHH = 1.7 Hz, 1 H, H-7), 8.63 (d,
3JHP = 17.5 Hz, 1 H, H-6), 8.88 (dd, 3JHH = 8.4 Hz, 4JHH = 1.7 Hz, 1
H, H-4), 9.21 (dd, 3JHH = 4.4 Hz, 4JHH = 1.7 Hz, 1 H, H-9), 9.27 (dd,
3JHH = 4.4 Hz, 4JHH = 1.7 Hz, 1 H, H-2).
13C NMR (75 MHz, CDCl3): δ = 16.49 (d, J = 6.3 Hz, 2 C, CH3),
62.78 (d, J = 5.3 Hz, 2 C, CH2), 123.46 (C-8), 123.83 (C-3), 126.68
(d, J = 122.6 Hz, C-5), 126.85 (d, J = 18.4 Hz, C-4a), 127.36 (C-
6a), 135.42 (d, J = 3.3 Hz, C-4), 136.88 (d, J = 8.8 Hz, C-6), 137.31
(C-7), 146.40 (d, J = 12.0 Hz, C-10b), 148.00 (d, J = 2.7 Hz, C-
10a), 150.71 (C-9), 152.68 (C-2).
IR (film): 2934, 1647, 1499, 1419, 1370, 1250, 1224, 1153, 1125,
1096, 1050, 1017, 973 cm–1.
1H NMR (300 MHz, CDCl3): δ = 1.29 (t, 3JHH = 7.1 Hz, 6 H, CH3),
3
4.13 (m, 2 H, CH2), 4.22 (m, 2 H, CH2), 7.62 (dd, JHH = 8.1 Hz,
3JHH = 4.3 Hz, 1 H, H-8), 7.87 (d, 3JHH = 9.1 Hz, 1 H, H-6), 8.14 (dd,
3
3
3JHP = 15.4 Hz, JHH = 4.3 Hz, 1 H, H-3), 8.23 (dd, JHH = 8.1 Hz,
4JHH = 1.7 Hz, 1 H, H-7), 8.49 (d, 3JHH = 9.1 Hz, 1 H, H-5), 9.17 (dd,
4
4
3JHH = 4.3 Hz, JHH = 1.7 Hz, 1 H, H-9), 9.26 (dd, JHP = 4.6 Hz,
3JHH = 4.5 Hz, 1 H, H-2).
13C NMR (75 MHz, CDCl3): δ = 16.48 (d, J = 6.1 Hz, 2 C, CH3),
63.14 (d, J = 5.5 Hz, 2 C, CH2), 123.71 (C-8), 124.95 (d, J = 4.5 Hz,
C-5), 127.84 (d, J = 7.1 Hz, C-3), 127.99 (d, J = 9.1 Hz, C-4a),
128.05 (C-6), 128.53 (C-6a), 134.72 (d, J = 180.4 Hz, C-4), 136.07
(C-7), 146.24 (C-10a), 146.82 (d, J = 11.0 Hz, C-10b), 149.57 (d,
J = 13.3 Hz, C-2), 150.82 (C-9).
31P NMR (121 MHz, CDCl3): δ = 16.65.
HRMS: m/z [M + Na]+ calcd for C16H17O3N2NaP: 339.0869; found:
339.0878.
Method B (Table 1, Entry 3)
Prepared from 5-bromo-1,10-phenanthroline (1; 130 mg, 0.5
mmol), Pd(OAc)2 (11.2 mg, 0.05 mmol), Ph3P (1.31 g, 5 mmol),
HP(O)(OEt)2 (77 μL, 0.6 mmol) and Et3N (80 μL, 0.6 mmol) in tol-
uene. The reaction mixture was chromatographed (CH2Cl2–MeOH,
98:2) to give the diethyl phosphonate 2 which was isolated as a yel-
low oil; yield: 73 mg (46%).
31P NMR (121 MHz, CDCl3): δ = 14.92.
HRMS: m/z [M + Na]+ calcd for C16H17O3N2NaP: 339.0869; found:
339.0877.
Diethyl 1,10-Phenanthrolin-2-ylphosphonate (9)
Prepared from 2-chloro-1,10-phenanthroline (6; 108 mg, 0.5
mmol), Pd(OAc)2 (11.2 mg, 0.05 mmol), dppf (55.4 mg, 0.1 mmol),
HP(O)(OEt)2 (77 μL, 0.6 mmol) and Et3N (80 μL, 0.6 mmol) in tol-
uene. Purification by column chromatography (CH2Cl2–MeOH,
96:4) gave phosphonate 9 as a yellow oil; yield: 112 mg (71%).
Elution with 25% NH3–MeOH–CH2Cl2 (1:4:20) gave triethylam-
monium ethyl 1,10-phenanthrolin-5-ylphosphonate (3) as a yellow
oil; yield: 45 mg (23%); purity >85% [impurity signals in the 1H and
31P NMR spectra are tentatively assigned to the tetraethylammoni-
um salt (5%) and ethyltriphenylphosphonium salt (10%)].
Synthesis 2012, 44, 3805–3810
© Georg Thieme Verlag Stuttgart · New York